Frontier Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.88M | Sell |
|
|||||
|
2024
Q1 | $6.96M | Sell |
|
|||||
|
2023
Q4 | $16M | Sell |
|
|||||
|
2023
Q3 | $12M | Sell |
|
|||||
|
2023
Q2 | $21.1M | Buy |
|
|||||
|
2023
Q1 | $2.1M | Sell |
|
|||||
|
2022
Q4 | $2.27M | Sell |
|
|||||
|
2022
Q3 | $20.8M | Buy |
|
|||||
|
2022
Q2 | $10.2M | Buy |
|
|||||
|
2022
Q1 | $9.29M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $488K | Sell |
|
|||||
|
2020
Q3 | $267K | Sell |
|
|||||
|
2020
Q2 | $11.7M | Buy |
|
|||||
|
2020
Q1 | $4.88M | Buy |
|
|||||
|
2019
Q4 | $4.67M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $3.21M | Buy |
|